Literature DB >> 15266209

A look at a Hispanic and African American population in an urban prenatal diagnostic center: referral reasons, amniocentesis acceptance, and abnormalities detected.

Debra Baker1, Senait Teklehaimanot, Rosetta Hassan, Carol Guze.   

Abstract

PURPOSE: To describe the Hispanic and African-American population referred to our inner city Los Angeles Prenatal Diagnostic Center. To evaluate trends in referral reasons, amniocentesis acceptance, and to assess the number and types of fetal abnormalities found from 1995 to 2001.
METHODS: A retrospective study using the data from 3085 daily log entries on patients referred for prenatal counseling. The data included race, age, referral reason, amniocentesis decision and results, and fetal abnormalities.
RESULTS: The population was 76% Hispanic and 22% African American. Most referrals were for advanced maternal age (42%) and maternal serum screening (28%). The overall amniocentesis acceptance rate was 52%; advanced maternal age amniocentesis acceptance rate was 46%, and maternal serum screen positive amniocentesis acceptance rate was significantly higher at 64%. There was a significant difference between the overall amniocentesis acceptance rate for Hispanics (48%) and African Americans (63%). There was also a significant downward trend in amniocentesis acceptance between 1995 (63%) and 2001 (39%). Amniocentesis acceptance was significantly greater among patients who were < 35 years of age (65%) than those who were older (47%). An incidence of 7% abnormalities was detected by ultrasound and amniocentesis.
CONCLUSIONS: Acceptance of amniocentesis in the Hispanic and African American population in our prenatal diagnostic center is significantly lower than what has previously been reported in the literature for Caucasians and reported in California statewide prenatal diagnostic center data for non-MS-AFP. There was a significant decline in amniocentesis acceptance from 1995 to 2001. Our incidence of fetal abnormalities was higher than reported in California statewide data.

Entities:  

Mesh:

Year:  2004        PMID: 15266209     DOI: 10.1097/01.gim.0000132684.94642.a0

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  8 in total

1.  Awareness and attitudes regarding prenatal testing among Texas women of childbearing age.

Authors:  Amy P Case; Tunu A Ramadhani; Mark A Canfield; Catherine A Wicklund
Journal:  J Genet Couns       Date:  2007-08-03       Impact factor: 2.537

2.  Knowledge and Prevention Practices among U.S. Pregnant Immigrants from Zika Virus Outbreak Areas.

Authors:  Abbey B Berenson; Ha N Trinh; Jacqueline M Hirth; Fangjian Guo; Erika L Fuchs; Scott C Weaver
Journal:  Am J Trop Med Hyg       Date:  2017-07       Impact factor: 2.345

3.  The Clinical Utility of Non-invasive Prenatal Testing for Pregnant Women With Different Diagnostic Indications.

Authors:  Jianli Zheng; Haiyan Lu; Min Li; Yongjuan Guan; Fangfang Yang; Mengjun Xu; Jingjing Dong; Qinge Zhang; Ning An; Yun Zhou
Journal:  Front Genet       Date:  2020-06-30       Impact factor: 4.599

Review 4.  Latinx individuals' knowledge of, preferences for, and experiences with prenatal genetic testing: a scoping review.

Authors:  Natalie Grafft; Andrew A Dwyer; María Pineros-Leano
Journal:  Reprod Health       Date:  2022-06-06       Impact factor: 3.355

5.  Selected birth defects data from population-based birth defects surveillance programs in the United States, 2006 to 2010: featuring trisomy conditions.

Authors:  Cara T Mai; James E Kucik; Jennifer Isenburg; Marcia L Feldkamp; Lisa K Marengo; Erin M Bugenske; Phoebe G Thorpe; Jodi M Jackson; Adolfo Correa; Russel Rickard; C J Alverson; Russell S Kirby
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2013-11

Review 6.  Global Birth Prevalence of Spina Bifida by Folic Acid Fortification Status: A Systematic Review and Meta-Analysis.

Authors:  Callie A M Atta; Kirsten M Fiest; Alexandra D Frolkis; Nathalie Jette; Tamara Pringsheim; Christine St Germaine-Smith; Thilinie Rajapakse; Gilaad G Kaplan; Amy Metcalfe
Journal:  Am J Public Health       Date:  2015-11-12       Impact factor: 9.308

7.  Frequency of prenatal cytogenetic diagnosis and pregnancy outcomes by maternal race-ethnicity, and the effect on the prevalence of trisomy 21, Metropolitan Atlanta, 1996-2005.

Authors:  Jodi M Jackson; Krista S Crider; Janet D Cragan; Sonja A Rasmussen; Richard S Olney
Journal:  Am J Med Genet A       Date:  2013-11-22       Impact factor: 2.802

8.  A Cost-Effectiveness Analysis of First Trimester Non-Invasive Prenatal Screening for Fetal Trisomies in the United States.

Authors:  Brandon S Walker; Richard E Nelson; Brian R Jackson; David G Grenache; Edward R Ashwood; Robert L Schmidt
Journal:  PLoS One       Date:  2015-07-02       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.